August 8, 2019
BELLUS Health Reports Net loss Canadian $7.9M for Second Quarter 2019
LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (TSX: BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for…